Oncology News

The incidence rate of early-onset cancer significantly increased in the United States from 2010 to 2019, particularly gastrointestinal cancers, according to researchers.

Abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities, according to results of a systematic review presented at ASCO Annual Meeting.

From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.

A cancer diagnosis can be terrifying for any patient, but when a colorectal cancer researcher is diagnosed with the same disease that they spent years studying, it also transforms how they practice medicine and how they relate to patients.

A microsimulation model showed a reduction in colorectal cancer disease burden and mortality when screening for CRC was initiated at ages 45 years or 40 years, which also added life-years to the population at a comparable health care cost.

Postmenopausal women who consumed at least one sugar-sweetened soft drink per day had significantly higher incidence of liver cancer and chronic liver disease mortality, compared with those who drank no more than three beverages per month.

A novel therapeutic approach that combined radiation and immunotherapy demonstrated the ability to eliminate pancreatic tumors and halt metastases.

Time from presentation to treatment did not affect survival among adults aged younger than 50 years with colorectal cancer, according to study results published in JAMA Network Open.

Surgery did not significantly increase the number of “good days” among patients with advanced cancer and malignant small bowel obstruction, according to study results.

The FDA approved trifluridine and tipiracil with bevacizumab for patients with previously treated metastatic colorectal cancer.